| GP10087-25mg |
|
484-42-4 |
Angiotensin I (human, mouse, rat)
|
0 |
— |
|
|
|
| GP10087-10mg |
|
484-42-4 |
Angiotensin I (human, mouse, rat)
|
0 |
— |
|
|
|
| GP10087-5mg |
|
484-42-4 |
Angiotensin I (human, mouse, rat)
|
0 |
— |
|
|
|
| GP10085-25mg |
|
141685-53-2 |
Thrombin Receptor Activator for Peptide 5 (TRAP-5)
|
0 |
— |
|
|
|
| GP10085-10mg |
|
141685-53-2 |
Thrombin Receptor Activator for Peptide 5 (TRAP-5)
|
0 |
— |
|
|
|
| GP10085-5mg |
|
141685-53-2 |
Thrombin Receptor Activator for Peptide 5 (TRAP-5)
|
0 |
— |
|
|
|
| GP10084-25mg |
|
— |
type II collagen fragment
|
0 |
— |
|
|
|
| GP10084-10mg |
|
— |
type II collagen fragment
|
0 |
— |
|
|
|
| GP10084-5mg |
|
— |
type II collagen fragment
|
0 |
— |
|
|
|
| GP10084-1mg |
|
— |
type II collagen fragment
|
0 |
— |
|
|
|
| GP10083-25mg |
|
190436-05-6 |
|
0 |
— |
|
|
|
| GP10083-10mg |
|
190436-05-6 |
|
0 |
— |
|
|
|
| GP10083-5mg |
|
190436-05-6 |
|
0 |
— |
|
|
|
| GP10083-1mg |
|
190436-05-6 |
|
0 |
— |
|
|
|
| GP10082-25mg |
|
131602-53-4 |
Amyloid Beta-peptide (25-35) (human)
|
0 |
— |
|
|
|
| GP10082-10mg |
|
131602-53-4 |
Amyloid Beta-peptide (25-35) (human)
|
0 |
— |
|
|
|
| GP10082-5mg |
|
131602-53-4 |
Amyloid Beta-peptide (25-35) (human)
|
0 |
— |
|
|
|
| GP10082-1mg |
|
131602-53-4 |
Amyloid Beta-peptide (25-35) (human)
|
0 |
— |
|
|
|
| GP10081-25mg |
|
59004-96-5 |
|
0 |
— |
|
|
|
| GP10081-10mg |
|
59004-96-5 |
|
0 |
— |
|
|
|
